Searched for
GLOBAL GENERIC BUSINESS DEVELOPMENT
India's GLP-1 boom slows amid price war, weak retentionInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Payoneer India Cross-Border Excellence Awards 2026: From fashion to wellness, spotlighting India's e-commerce export championsThe Payoneer India Cross-Border Excellence Awards 2026 celebrate India's rising exporters, spotlighting e-commerce leaders in fashion, home...
- Manglam Group to invest Rs 350 crore in Sheraton hotel in JaipurRajasthan's Manglam Group is investing Rs 350 crore to build a 220-key Sheraton Hotel on the Jaipur-Ajmer Highway, marking their third part...
- India is helping shape our global product portfolio, engineering decisions, and technology roadmap: Schneider Electric CHROSchneider Electric's India operations have evolved into a crucial global hub, housing over 38,000 employees and driving enterprise-wide out...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Tata Motors CV bets on global expansion, EVs and digital businesses for next phase of growthTata Motors' commercial vehicle division is charting an ambitious growth path, prioritizing global expansion, electric vehicles, and digita...
- Tax reforms to play vital role in attracting global capital to India: ExpertsIndia's economic ascent hinges on predictable and simplified tax reforms to attract global capital, according to a senior financial expert....
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- Nestle, Uber among global business leaders to back faster electrification shiftOver 100 global companies, including Nestle and Uber, are urging governments to prioritize electrification in economic strategies. They arg...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Service exports are powering India's global growth story. It's time to recognise the businesses behind it.As India's services sector drives global growth, the Payoneer India Cross-Border Excellence Awards 2026 celebrate businesses exporting inno...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
Load More
